REPOTRECTINIB

REPOTRECTINIB was reported 274 times

REPOTRECTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MORBILLIVIRUS TEST POSITIVE 1 0.2000
1 BREAST ANGIOSARCOMA METASTATIC 1 0.1250
2 RUBIVIRUS TEST POSITIVE 1 0.0625
3 VARICELLA MENINGITIS 2 0.0400
4 RUBULAVIRUS TEST POSITIVE 1 0.0385
5 GLUTAMATE DEHYDROGENASE INCREASED 1 0.0090
6 PANCREATIC LEAK 1 0.0089
7 ROSEOLOVIRUS TEST POSITIVE 1 0.0082
8 HYPERADRENOCORTICISM 2 0.0073
9 EAR, NOSE AND THROAT DISORDER 1 0.0071
10 MYCOPLASMA TEST POSITIVE 1 0.0066
11 PHARYNGEAL CANCER 1 0.0056
12 ADRENOMEGALY 1 0.0048
13 CARDIAC SEPTAL HYPERTROPHY 1 0.0036
14 SALIVARY GLAND NEOPLASM 1 0.0035
15 HYPERTENSIVE ENCEPHALOPATHY 2 0.0034
16 CENTRAL HYPOTHYROIDISM 1 0.0030
17 VASCULAR STENOSIS 1 0.0029
18 CHYLOTHORAX 2 0.0028
19 ANAESTHESIA 1 0.0027
20 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
21 NON-SMALL CELL LUNG CANCER METASTATIC 2 0.0023
22 CEREBRAL MICROHAEMORRHAGE 1 0.0022
23 BLOOD GASES ABNORMAL 1 0.0019
24 ADRENAL HAEMORRHAGE 1 0.0018
25 RADIATION NECROSIS 1 0.0017
26 HEAD AND NECK CANCER 1 0.0015
27 MYASTHENIC SYNDROME 1 0.0013
28 PRODUCT INEFFECTIVE 1 0.0013
29 MEAN PLATELET VOLUME DECREASED 1 0.0012
30 ATONIC SEIZURES 1 0.0012
31 PHARYNGEAL HYPOAESTHESIA 1 0.0011
32 STREPTOCOCCAL BACTERAEMIA 1 0.0009
33 SARCOMA 1 0.0009
34 METASTASES TO MENINGES 2 0.0009
35 COLON OPERATION 1 0.0008
36 ESCHERICHIA TEST POSITIVE 1 0.0008
37 BILE DUCT STENOSIS 1 0.0008
38 PRODUCT STORAGE ISSUE 3 0.0008
39 ISCHAEMIC HEPATITIS 1 0.0007
40 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
41 INVESTIGATION ABNORMAL 1 0.0007
42 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
43 MEAN CELL VOLUME DECREASED 1 0.0006
44 NON-SMALL CELL LUNG CANCER 3 0.0006
45 TROPONIN I INCREASED 1 0.0006
46 MALIGNANT PLEURAL EFFUSION 1 0.0006
47 ATAXIA 7 0.0006
48 MITRAL VALVE DISEASE 1 0.0006
49 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
50 SINUS NODE DYSFUNCTION 1 0.0005
51 BLADDER SPASM 1 0.0005
52 HYPOGEUSIA 1 0.0005
53 CELL DEATH 1 0.0005
54 LYMPHOCYTOSIS 1 0.0005
55 RENAL FUNCTION TEST ABNORMAL 2 0.0004
56 URINARY HESITATION 1 0.0004
57 SUFFOCATION FEELING 1 0.0004
58 MOTOR DYSFUNCTION 4 0.0004
59 CHONDROPATHY 1 0.0004
60 HYPERAESTHESIA 3 0.0004
61 NEUROLOGICAL SYMPTOM 2 0.0003
62 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
63 LUNG CANCER METASTATIC 1 0.0003
64 TASTE DISORDER 7 0.0003
65 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
66 LUNG ADENOCARCINOMA 1 0.0003
67 HYPERCAPNIA 1 0.0003
68 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
69 SWELLING OF EYELID 2 0.0003
70 ORTHOPNOEA 1 0.0003
71 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
72 SKIN EROSION 1 0.0003
73 HEPATIC CYST 1 0.0003
74 MONOCYTE COUNT INCREASED 1 0.0003
75 SENSITIVE SKIN 2 0.0003
76 AFFECTIVE DISORDER 2 0.0003
77 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
78 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
79 TONGUE DISCOMFORT 1 0.0002
80 SKIN ABRASION 1 0.0002
81 CARDIAC TAMPONADE 1 0.0002
82 ATELECTASIS 2 0.0002
83 HYPOAESTHESIA ORAL 3 0.0002
84 ERYSIPELAS 1 0.0002
85 FAILURE TO THRIVE 1 0.0002
86 SENSITIVITY TO WEATHER CHANGE 1 0.0002
87 NEUROPATHY PERIPHERAL 18 0.0002
88 SUDDEN DEATH 2 0.0002
89 PRODUCT SIZE ISSUE 1 0.0002
90 STRESS FRACTURE 1 0.0002
91 BEHAVIOUR DISORDER 1 0.0002
92 JAW DISORDER 1 0.0002
93 DEAFNESS UNILATERAL 1 0.0002
94 HYPERKERATOSIS 1 0.0002
95 GASTRIC ULCER HAEMORRHAGE 1 0.0002
96 CHOLECYSTITIS ACUTE 1 0.0002
97 PERICARDIAL EFFUSION 4 0.0002
98 NEUROTOXICITY 3 0.0002
99 HYPERTRIGLYCERIDAEMIA 1 0.0002
100 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
101 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
102 DRUG RESISTANCE 4 0.0002
103 GAIT INABILITY 5 0.0001
104 TREATMENT NONCOMPLIANCE 8 0.0001
105 JOINT EFFUSION 1 0.0001
106 ENCEPHALITIS 1 0.0001
107 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
108 CEREBRAL DISORDER 1 0.0001
109 TRANSAMINASES INCREASED 3 0.0001
110 TROPONIN INCREASED 1 0.0001
111 ADVERSE EVENT 12 0.0001
112 NERVOUS SYSTEM DISORDER 4 0.0001
113 BRAIN FOG 2 0.0001
114 RENAL CYST 1 0.0001
115 TRICUSPID VALVE INCOMPETENCE 1 0.0001
116 MYASTHENIA GRAVIS 1 0.0001
117 HEMIPLEGIA 1 0.0001
118 MYOPATHY 1 0.0001
119 GRIP STRENGTH DECREASED 1 0.0001
120 BRAIN NEOPLASM 1 0.0001
121 IRON DEFICIENCY ANAEMIA 1 0.0001
122 SPINAL DISORDER 1 0.0001
123 BALANCE DISORDER 9 0.0001
124 HYPERCHOLESTEROLAEMIA 1 0.0001
125 PHARYNGEAL SWELLING 1 0.0001
126 THERAPY CHANGE 1 0.0001
127 PLEURAL EFFUSION 6 0.0001
128 TEMPERATURE INTOLERANCE 1 0.0001
129 MUSCULAR WEAKNESS 11 0.0001
130 PULMONARY EMBOLISM 9 0.0001
131 FULL BLOOD COUNT ABNORMAL 1 0.0001
132 LIVER FUNCTION TEST INCREASED 2 0.0001
133 NERVE INJURY 1 0.0001
134 MALNUTRITION 1 0.0001
135 OCULAR DISCOMFORT 1 0.0001
136 BLOOD CALCIUM DECREASED 1 0.0001
137 DIZZINESS 44 0.0001
138 SCAB 1 0.0001
139 MYOCARDITIS 1 0.0001
140 NEURALGIA 2 0.0001
141 CYTOPENIA 1 0.0001
142 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
143 SPINAL OPERATION 1 0.0001
144 DYSGEUSIA 6 0.0001
145 AGEUSIA 2 0.0001
146 PNEUMONIA ASPIRATION 2 0.0001
147 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
148 PLATELET COUNT INCREASED 1 0.0001
149 HAND DEFORMITY 1 0.0001
150 PULMONARY CONGESTION 1 0.0001
151 PNEUMONITIS 2 0.0001
152 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
153 SUBDURAL HAEMATOMA 1 0.0001
154 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
155 DYSSTASIA 2 0.0001
156 CARDIOMYOPATHY 1 0.0001
157 ADVERSE DRUG REACTION 6 0.0001
158 BONE LOSS 1 0.0001
159 DELUSION 1 0.0001
160 PARAESTHESIA 10 0.0001
161 PRODUCT USE COMPLAINT 1 0.0001
162 DYSPHAGIA 6 0.0001
163 PNEUMOTHORAX 1 0.0001
164 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
165 MUSCULOSKELETAL DISCOMFORT 1 0.0001
166 DELIRIUM 2 0.0001
167 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
168 DISTURBANCE IN ATTENTION 3 0.0001
169 LEUKOCYTOSIS 1 0.0001
170 OSTEOMYELITIS 1 0.0001
171 RESTLESS LEGS SYNDROME 1 0.0001
172 MIDDLE INSOMNIA 1 0.0001
173 HOSPITALISATION 8 0.0001
174 ACUTE RESPIRATORY FAILURE 1 0.0001
175 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
176 HAEMATOCRIT DECREASED 1 0.0001
177 FEEDING DISORDER 1 0.0000
178 VERTIGO 3 0.0000
179 PULMONARY HYPERTENSION 1 0.0000
180 GAIT DISTURBANCE 9 0.0000
181 EATING DISORDER 1 0.0000
182 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
183 HEPATOTOXICITY 1 0.0000
184 PULMONARY OEDEMA 2 0.0000
185 MUSCLE TWITCHING 1 0.0000
186 SEIZURE 5 0.0000
187 COGNITIVE DISORDER 2 0.0000
188 ANAEMIA 8 0.0000
189 MYALGIA 7 0.0000
190 LIVER INJURY 1 0.0000
191 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
192 HALLUCINATION 3 0.0000
193 UNRESPONSIVE TO STIMULI 1 0.0000
194 SKIN ULCER 1 0.0000
195 MUSCULOSKELETAL PAIN 2 0.0000
196 SPEECH DISORDER 2 0.0000
197 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
198 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
199 PAIN OF SKIN 1 0.0000
200 CONSTIPATION 8 0.0000
201 MEMORY IMPAIRMENT 5 0.0000
202 MENTAL STATUS CHANGES 1 0.0000
203 FEELING COLD 1 0.0000
204 NECK PAIN 2 0.0000
205 DEMENTIA 1 0.0000
206 WOUND 1 0.0000
207 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
208 PAIN IN JAW 1 0.0000
209 LIVER FUNCTION TEST ABNORMAL 1 0.0000
210 PRODUCT STORAGE ERROR 3 0.0000
211 ASCITES 1 0.0000
212 ACUTE MYOCARDIAL INFARCTION 1 0.0000
213 DISEASE PROGRESSION 4 0.0000
214 BLOOD POTASSIUM DECREASED 1 0.0000
215 EPILEPSY 1 0.0000
216 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
217 DEATH 28 0.0000
218 EMOTIONAL DISORDER 1 0.0000
219 FEMUR FRACTURE 1 0.0000
220 IMPAIRED HEALING 1 0.0000
221 OSTEONECROSIS 1 0.0000
222 SKIN DISORDER 1 0.0000
223 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
224 HEPATIC ENZYME INCREASED 2 0.0000
225 NEOPLASM PROGRESSION 1 0.0000
226 HYPOXIA 1 0.0000
227 THERAPY INTERRUPTED 2 0.0000
228 MOBILITY DECREASED 2 0.0000
229 MYELOSUPPRESSION 1 0.0000
230 PRODUCT USE ISSUE 5 0.0000
231 DYSPNOEA EXERTIONAL 1 0.0000
232 NAUSEA 21 0.0000
233 ACNE 2 0.0000
234 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
235 DISORIENTATION 1 0.0000
236 CARDIAC FAILURE 2 0.0000
237 EXTRA DOSE ADMINISTERED 1 0.0000
238 OEDEMA PERIPHERAL 3 0.0000
239 TOXICITY TO VARIOUS AGENTS 4 0.0000
240 OSTEOARTHRITIS 1 0.0000
241 MENTAL DISORDER 1 0.0000
242 SUICIDAL IDEATION 2 0.0000
243 NEPHROLITHIASIS 1 0.0000
244 TINNITUS 1 0.0000
245 NASOPHARYNGITIS 4 0.0000
246 OFF LABEL USE 19 0.0000
247 RENAL DISORDER 1 0.0000
248 SWELLING 2 0.0000
249 COMA 1 0.0000
250 DRUG INTOLERANCE 2 0.0000
251 HYPOGLYCAEMIA 1 0.0000
252 HYPOAESTHESIA 3 0.0000
253 LEUKOPENIA 1 0.0000
254 SOMNOLENCE 4 0.0000
255 CONDITION AGGRAVATED 6 0.0000
256 FLUID RETENTION 1 0.0000
257 BLOOD PRESSURE INCREASED 3 0.0000
258 PAIN 12 0.0000
259 CHEST DISCOMFORT 2 0.0000
260 PERIPHERAL SWELLING 3 0.0000
261 ILLNESS 2 0.0000
262 ABDOMINAL DISTENSION 2 0.0000
263 NERVOUSNESS 1 0.0000
264 DRUG INTERACTION 3 0.0000
265 BRADYCARDIA 1 0.0000
266 RASH PRURITIC 1 0.0000
267 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
268 FALL 6 0.0000
269 ARTHROPATHY 1 0.0000
270 WEIGHT INCREASED 4 0.0000
271 OXYGEN SATURATION DECREASED 1 0.0000
272 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
273 BONE PAIN 1 0.0000
274 FATIGUE 13 0.0000
275 VISUAL IMPAIRMENT 2 0.0000
276 PNEUMONIA 5 0.0000
277 DEEP VEIN THROMBOSIS 1 0.0000
278 SWELLING FACE 1 0.0000
279 BLOOD CREATININE INCREASED 1 0.0000
280 RENAL FAILURE 2 0.0000
281 DRY SKIN 2 0.0000
282 HYPOTENSION 3 0.0000
283 VOMITING 7 0.0000
284 VISION BLURRED 2 0.0000
285 ARTHRALGIA 6 0.0000
286 SKIN BURNING SENSATION 1 0.0000
287 DIARRHOEA 9 0.0000
288 INFECTION 2 0.0000
289 RASH 6 0.0000
290 RESPIRATORY FAILURE 1 0.0000
291 AGITATION 1 0.0000
292 PAIN IN EXTREMITY 4 0.0000
293 ACUTE KIDNEY INJURY 2 0.0000
294 ABDOMINAL PAIN 3 0.0000
295 ARTHRITIS 1 0.0000
296 CARDIAC FAILURE CONGESTIVE 1 0.0000
297 THROMBOSIS 1 0.0000
298 CONFUSIONAL STATE 2 0.0000
299 DYSPNOEA 7 0.0000
300 DRY MOUTH 1 0.0000
301 URINARY TRACT INFECTION 2 0.0000
302 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
303 GASTROINTESTINAL DISORDER 1 0.0000
304 MIGRAINE 1 0.0000
305 SYNCOPE 1 0.0000
306 HAEMOGLOBIN DECREASED 1 0.0000
307 HEADACHE 6 0.0000
308 HAEMORRHAGE 1 0.0000
309 HYPERTENSION 2 0.0000
310 MALAISE 4 0.0000
311 INFLUENZA 1 0.0000
312 THROMBOCYTOPENIA 1 0.0000
313 DECREASED APPETITE 2 0.0000
314 FEELING ABNORMAL 2 0.0000
315 JOINT SWELLING 1 0.0000
316 EMOTIONAL DISTRESS 1 0.0000
317 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
318 ASTHENIA 3 0.0000
319 LOSS OF CONSCIOUSNESS 1 0.0000
320 HYPERHIDROSIS 1 0.0000
321 DEHYDRATION 1 0.0000
322 NEUTROPENIA 1 0.0000
323 PRODUCT DOSE OMISSION ISSUE 2 0.0000
324 ABDOMINAL DISCOMFORT 1 0.0000
325 CEREBROVASCULAR ACCIDENT 1 0.0000
326 MYOCARDIAL INFARCTION 1 0.0000
327 COVID-19 1 0.0000
328 MUSCLE SPASMS 1 0.0000
329 HYPERSENSITIVITY 1 0.0000
330 BLOOD GLUCOSE INCREASED 1 0.0000
331 ALOPECIA 1 0.0000
332 ABDOMINAL PAIN UPPER 1 0.0000
333 OVERDOSE 1 0.0000
334 DRUG INEFFECTIVE 6 0.0000
335 BACK PAIN 1 0.0000
336 INSOMNIA 1 0.0000
337 COUGH 1 0.0000
338 ANXIETY 1 0.0000
339 PYREXIA 1 0.0000
340 PRURITUS 1 0.0000